Abstract:The cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and the thin filament. Mutations in troponin can cause cardiomyopathies; however, it is still a major challenge for the field to connect how changes in sequence affect troponin's function. Recent high-resolution structures of the thin filament revealed critical insights into the structure-function relationship of the troponin complex, but there remain large, unresolved segments of troponin, including the troponin-T linker region that is a hotspot for several cardiomyopathy mutations. This unresolved yet functionally-significant linker region has been proposed to be intrinsically disordered, with behaviors that are not well described by traditional structural approaches; however, this proposal has not been experimentally verified. Here, we used a combination of single-molecule Forster resonance energy transfer (FRET), molecular dynamics simulations, and functional reconstitution assays to investigate the troponin-T linker region. We experimentally and computationally show that in the context of both isolated troponin and the fully regulated troponin complex, the linker behaves as a dynamic, intrinsically disordered region. This region undergoes polyampholyte expansion in the presence of high salt and distinct conformational changes during the assembly of the troponin complex. We also examine the ΔE160 hypertrophic cardiomyopathy mutation in the linker, and we demonstrate that this mutation does not affect the conformational dynamics of the linker, rather it allosterically affects interactions with other subunits of the troponin complex, leading to increased molecular contractility. Taken together, our data clearly demonstrate the importance of disorder within the troponin-T linker and provide new insights into the molecular mechanisms controlling the pathogenesis of cardiomyopathies.

Synthesis and Biophysical Characterization of Fingolimod Derivatives as Cardiac Troponin Antagonists

Derivation of Inhibitory Peptides to Target the Cardiac Troponin C–I Interaction As Potential Therapeutics for Heart Failure

Myofilament Calcium Sensitivity: Consequences of the Effective Concentration of Troponin I

Molecular dynamics provides new insights into the mechanism of calcium signal transduction and interdomain interactions in cardiac troponin

Actin-binding compounds that affect the kinetics of the interaction of cardiac myosin with actin

Mechanistic analysis of actin-binding compounds that affect the kinetics of cardiac myosin-actin interaction

Adaptative Steered Molecular Dynamics Study of Mutagenesis Effects on Calcium Affinity in the Regulatory Domain of Cardiac Troponin C

Neutraceuticals silybin B, resveratrol and epigallocatechin-3 gallate (EGCG) bind to troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico

Structural dynamics of the intrinsically disordered linker region of cardiac troponin T

Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitor

Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.

Development and characterization of anti-fibrotic natural compound similars with improved effectivity

Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen

Drug discovery for heart failure targeting myosin-binding protein C

Synthesis and biological evaluation of lycoctonine derivatives with cardiotonic and calcium channels inhibitory activities

Danicamtiv reduces myosin's working stroke but enhances contraction by activating the thin filament

Molecular Insights into the Calcium Binding in Troponin C through a Molecular Dynamics Study

Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility

Molecular dynamics of hERG channel: insights into understanding the binding of small molecules for detuning cardiotoxicity

Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators

Danicamtiv Increases Myosin Recruitment and Alters Cross-Bridge Cycling in Cardiac Muscle